One additional newsworthy item for your list will be RenovoRX presentation of their phase 3 results next weekend.
"We are pleased to present research supporting our TAMP therapy platform at the upcoming SIR 2024 conference, the largest professional gathering of interventional radiologists in North America,” said Shaun Bagai, CEO.
I know it’s not exactly IMU and yet it will potentially have a direct impact on a small part of our future trials.
One additional newsworthy item for your list will be RenovoRX...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.7¢ |
Change
0.005(6.10%) |
Mkt cap ! $636.8M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.7¢ | 8.1¢ | $2.038M | 23.95M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 368920 | 8.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.7¢ | 926145 | 8 |
View Market Depth
| Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.7¢ |
Change
0.005 ( 5.84 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.7¢ | 8.2¢ | 7795679 | ||
| Last updated 15.59pm 30/04/2024 ? | |||||
| IMU (ASX) Chart |